Navigation Links
CTI Issues Statement Regarding Tosedostat Clinical Trial
Date:6/24/2013

SEATTLE, June 25, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today issued the following statement regarding the notification of the U.S. Food and Drug Administration (the "FDA") partial clinical hold on tosedostat (IND 075503), the Company's aminopeptidase inhibitor under development for the treatment of blood-related cancers, that is being studied in an investigator-sponsored trial and not by CTI. CTI's primary development programs are the ongoing Phase 3 trial of pacritinib, the Company's JAK2/FLT3 inhibitor being evaluated for patients with myelofibrosis, and the post-approval commitment study of PIXUVRI® (pixantrone).

This is a partial clinical hold of only part of the clinical work requested under the investigational new drug ("IND") application. Under a partial clinical hold, although a specific protocol or part of a protocol is not allowed to proceed, other parts of such protocol or other protocols are allowed to proceed under the IND. With this partial clinical hold, the Company may not enter new patients onto any of the ongoing tosedostat protocols until agreement is reached with the FDA.

After a study has been placed on partial clinical hold, the sponsor provides additional information and discusses the adverse event with the FDA to understand whether or not it was associated with the drug or due to another cause. The Company has begun work to comply with the FDA request and expects to be able to submit these data to the FDA in the coming weeks. For additional information, please refer to the Current Report on Form 8-K filed by the Company on June 24, 2013.

Recent Tosedostat Publication
In March 2013, Lancet Oncology published results from the OPAL Phase 2 study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia (AML). The trial showed that once-daily oral tosedostat resulted in a disease contro
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests
2. Celsion Corporation Issues Statement Regarding Misleading Blog Entry
3. Zydus Pharmaceuticals USA Inc. Issues Voluntary Nationwide Recall of Warfarin 2 mg Tablets, Lot MM5767, Expiration Date June 2014, Due to Oversized Tablets
4. Endeavor Power Corporation Issues Corrections on two of its earlier Press Releases dated January 9, 2013 and March 8, 2013
5. Neiman Center Issues Policy Brief Outlining Innovative Health Care Payment Models to Provide Cost-Effective Specialty Care for Patients
6. ISPE Patient Initiative Issues Survey Regarding Patient Experience with Clinical Materials
7. Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog
8. American Academy of Ophthalmology Issues Statement on Provisions to Pharmaceutical Compounding Quality and Accountability Act
9. Royalty Pharma Issues Investor Presentation Highlighting The Strategic And Financial Advantages Of Its Offer To Acquire Elan For $12.50 Per Share In Cash
10. BD Issues 2012 Sustainability Report
11. TNI BioTech, Inc. Corporations CEO Issues Letter to Shareholders Discussing Recent Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... , July 21, 2014  AVT, Inc. ... in automated retailing, micro-stores, custom vending machines and ... their automated medicine dispensing systems, which can be ... clinics and marijuana dispensaries. AVT,s newly designed systems ... of medicines and regulated products. "We ...
(Date:7/21/2014)... 2014  Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ... Administration (FDA) accepted the company,s Investigational New Drug (IND) ... and efficacy of AVP-786, Avanir,s next generation compound. The ... the adjunctive treatment of major depressive disorder (MDD) during ... "The endorsement of this Phase II study by the ...
(Date:7/21/2014)... July 21, 2014   Aventura , the leader ... announced today that MemorialCare Health System , ... computing solution at the Orange Coast Memorial ... Orange Coast Memorial is a 218-bed ... 12,000 patients annually. The Aventura Roaming Aware Desktop ...
Breaking Medicine Technology:Technology Driving Cannabis Industry 2Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 2Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 3Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 4Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 5MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 2MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 3MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 4
... Patent Office has awarded COPAN the much awaited patent for ... samples. This grant, deriving from a very thorough and careful ... flocked swab invention. COPAN,s revolutionary invention has now been awarded ...   " We are thrilled to receive ...
... -- The Ministry of Health and Welfare (Minister ... Institute (President Ko Kyung-hwa) launched a project to ... by designating 38 tasks, including seven major issues ... injuries and granting permission for drug dispensing in ...
Cached Medicine Technology:US Patent Office Grants COPAN Invention of Flocked Swabs 2Medical Korea's Medical Policy Improvement Project for Foreign Patients 2
(Date:7/22/2014)... July 22, 2014 Get Real ... Immune Deficiency Foundation (IDF) to provide their ... that will allow them to electronically track their symptoms, ... their illnesses. It will also allow those patients and ... consent to have their data shared with the ...
(Date:7/22/2014)... 22, 2014 JumpSoft, Inc., a ... automated recovery at the application level, today released ... to application-centric management. , Based on ... the report provides insights, context and depth regarding ... application and system uptime. London, Ink, a B2B ...
(Date:7/22/2014)... Recently, MyDressCity.com has excitedly launched a promotion ... moment, all people can get a discount, up to 60% ... in the new range; all the new items are of ... prettiest Quinceanera gowns for worldwide clients. Our dress specialists are ... CEO of MyDressCity.com, “Our Quinceanera dresses are selling well in ...
(Date:7/22/2014)... NY (PRWEB) July 22, 2014 BlackBox ... Blast Gauge™ System with advancements including a ... The new gauges represent a functional revision of the ... capability to capture complex data on blast events by ... resulting accelerations. The extreme changes in overpressure that accompany ...
(Date:7/22/2014)... "The Big Secrets: Ten Things Every Young Person ... important books young people can read. , But be careful! What’s ... the “truths” people have been living with all their lives. And ... be? From sex to death, this self-help book deals directly with ... it tells it like it is. , Tune in to “The ...
Breaking Medicine News(10 mins):Health News:Get Real Health to Partner with Immune Deficiency Foundation 2Health News:Get Real Health to Partner with Immune Deficiency Foundation 3Health News:JumpSoft Releases Report on Shift from Infrastructure-Centric to Application-Centric IT Management 2Health News:JumpSoft Releases Report on Shift from Infrastructure-Centric to Application-Centric IT Management 3Health News:Beautiful Dama Dresses Now Released By Popular Online Supplier MyDressCity.com 2Health News:BlackBox Biometrics®, Inc. continues to advance blast overpressure measurement with release of new Blast Gauge 2Health News:BlackBox Biometrics®, Inc. continues to advance blast overpressure measurement with release of new Blast Gauge 3Health News:Strategic Book Publishing & Rights Agency Announces the Release of its Newest Title, “The Big Secrets: Ten Things Every Young Person Should Know About and Why” 2
... San Diego Moores Cancer Center researchers and surgeons are ... with recurrent brain cancer by directly injecting an investigational ... developed by a local San Diego Company, Tocagen Inc. ... the deadliest forms of brain tumor," said principal investigator ...
... nutrient found in the dark meat of poultry may provide ... cholesterol, according to a study by researchers at NYU Langone ... European Journal of Nutrition , evaluated the effects of ... turkey and chicken, as well as in some fish and ...
... , THURSDAY, March 1 (HealthDay News) - Here,s one more ... you are an older woman: A new study found a ... ate the highest amount of this common ingredient in baked ... at the University of North Carolina in Chapel Hill, did ...
... A team of 18 researchers at Moffitt Cancer Center ... sarcoma patients with a combination of implanted dendritic cells (immune ... than 50 percent of their trial patients with tumor-specific immune ... study was published in a recent issue of the ...
... 1, 2012) Imaging amino acid transporters with ... to significantly alter intended management plans for patients ... March issue of The Journal of Nuclear ... the radiopharmaceutical 3,4-dihydroxy-6-F-18-fluoro-L-phenylalanine (F-18-DOPA), physicians changed the intended ...
... of leukaemia treatment and survival in Northern Ireland by the ... survival rates for the disease here are at the highest ... children with the disease, survival has improved dramatically from under ... level of over 80 per cent for five year survival. ...
Cached Medicine News:Health News:UC San Diego among first in nation to treat brain cancer with novel viral vector 2Health News:Nutrient found in dark meat of poultry, some seafood, may have cardiovascular benefits 2Health News:Nutrient found in dark meat of poultry, some seafood, may have cardiovascular benefits 3Health News:Trans Fats May Raise Stroke Risk in Older Women 2Health News:Trans Fats May Raise Stroke Risk in Older Women 3Health News:Researchers find sarcoma tumor immune response with combination therapy 2Health News:PET tracer changes management plan for brain tumor patients 2Health News:New study reveals more people surviving leukaemia and pancreatic cancer in Northern Ireland 2Health News:New study reveals more people surviving leukaemia and pancreatic cancer in Northern Ireland 3
... facilitates real time information collection. It ... first module is a software link ... the database where information is captured ... the user interface, which allows access ...
... provides a solution for instantaneously locating ... or unauthorized movement of patients or ... key concern. Certain patients, such as ... patients with highly communicable diseases, patients ...
... PDC Smart™ Labels have a direct ... Texas Instruments Tag-it™ HF-I transponder. When ... codes, text and other graphics may ... variable data is programmed to the ...
PDC RFID Smart™ Cards can be printed and programmed using a dye-sublimation card printer & programmer....
Medicine Products: